| |
| |
|
| Insider
Information: |
Berstein David L |
| Relationship: |
SVP, Chief IP Counsel |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
262,115 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
262,115 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ariad Pharmaceuticals Inc |
ARIA |
SVP, Chief IP Counsel |
2016-03-21 |
262,115 |
2003-09-16 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
76 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ARIA |
Ariad Pharmaceuticals Inc |
Senior VP, Chief IP Officer |
• – – |
2008-10-12 |
4 |
A |
$0.00 |
$0 |
D/D |
28,570 |
131,323 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Senior VP, Chief IP Officer |
• – – |
2011-03-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
26,334 |
190,419 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Senior VP, Chief IP Officer |
• – – |
2011-04-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
22,000 |
205,786 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Senior VP, Chief IP Officer |
• – – |
2012-03-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
47,000 |
245,256 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Senior VP, Chief IP Officer |
• – – |
2012-03-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
26,333 |
252,789 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Senior VP, Chief IP Officer |
• • – |
2012-12-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,000 |
190,856 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Senior VP, Chief IP Officer |
• • – |
2013-03-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,000 |
191,098 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Senior VP, Chief IP Officer |
• • – |
2013-03-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
26,333 |
215,831 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Senior VP, Chief IP Officer |
• • – |
2013-04-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,000 |
211,298 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Senior VP, Chief IP Officer |
• • – |
2013-07-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,000 |
224,898 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Senior VP, Chief IP Officer |
• • – |
2013-12-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,000 |
225,898 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, GC and Chief IP Officer |
• • – |
2014-03-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,750 |
226,148 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, GC and Chief IP Officer |
• • – |
2014-03-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,000 |
228,642 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, GC and Chief IP Officer |
• • – |
2014-04-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,000 |
233,042 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, GC and Chief IP Officer |
• • – |
2014-07-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,000 |
238,642 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Chief IP Counsel |
• • – |
2015-02-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
29,334 |
236,741 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Chief IP Counsel |
• • – |
2015-03-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,750 |
226,824 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Chief IP Counsel |
• • – |
2015-03-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,000 |
228,449 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Chief IP Counsel |
• • – |
2015-07-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,000 |
234,449 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Chief IP Counsel |
• • – |
2015-09-24 |
4/A |
OE |
$0.00 |
$0 |
D/D |
10,000 |
240,449 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Chief IP Counsel |
• • – |
2015-09-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,000 |
250,449 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Chief IP Counsel |
• • – |
2016-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
29,333 |
264,782 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Chief IP Counsel |
• • – |
2016-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
19,250 |
269,365 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Chief IP Counsel |
• – – |
2016-03-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,750 |
264,490 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Senior VP Chief Patent Counsel |
• – – |
2004-01-07 |
4 |
OE |
$2.00 |
$7,142 |
D/D |
3,571 |
15,753 |
|
- |
|
76 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
